Durable and dramatic response to checkpoint inhibition combined with COX-2 inhibitor celecoxib in a patient with p16+ metastatic sinonasal undifferentiated carcinoma: A case study.

Trinh, Jonathan Q; Acosta, Cassaundra; Easwar, Arti; Galamaga, Robert; Tan, Alan

Trinh, Jonathan Q; Acosta, Cassaundra; Easwar, Arti; Galamaga, Robert; Tan, Alan.

Afiliación

Trinh JQ; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Acosta C; Department of Medical Oncology and Hematology, City of Hope, Goodyear, Arizona, USA.
Easwar A; Department of Pathology and Laboratory Medicine, City of Hope, Goodyear, Arizona, USA.
Galamaga R; Department of Medical Oncology and Hematology, City of Hope, Goodyear, Arizona, USA.
Tan A; Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.

Cancer Rep (Hoboken) ; 7(1): e1915, 2024 01.

Article en En | MEDLINE | ID: mdl-37867289

Asunto(s)

Carcinoma; Neoplasias del Seno Maxilar; Femenino; Humanos; Persona de Mediana Edad; Celecoxib/farmacología; Inhibidores de la Ciclooxigenasa 2/farmacología; Neoplasias del Seno Maxilar/patología; Neoplasias del Seno Maxilar/terapia; Carcinoma/patología

Palabras clave

IDO1; dual checkpoint inhibition; immunotherapy; metastatic; sinonasal undifferentiated carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Seno Maxilar / Carcinoma Límite: Female / Humans / Middle aged Idioma: En Revista: Cancer Rep (Hoboken) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google